How to diagnose the cause of sudden cardiac arrest

Cardiology Journal

Volumn 18, Issue 2, 2011, Pages 210-216

  Lim, Hoong Sern ^a   Subbiah, Rajesh N ^a   Leong Sit, Peter ^b   Gula, Lorne J ^b   Skanes, Allan C ^b   Yee, Raymond ^b   Klein, George J ^b   Krahn, Andrew D ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Cardiac arrest; Diagnosis; Genetics

Indexed keywords

ADRENALIN; AJMALINE; FLECAINIDE; GADOLINIUM; PROCAINAMIDE; SODIUM CHANNEL BLOCKING AGENT;

ACUTE HEART INFARCTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTRAST ENHANCEMENT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; ELECTROPHYSIOLOGY; EXERCISE; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC DISORDER; GENETICS; HEART ARREST; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE BIOPSY; HEART REPOLARIZATION; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; QRS COMPLEX; QT INTERVAL; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; ST SEGMENT; SUDDEN CARDIAC ARREST; SURVIVOR; SYMPTOMATOLOGY;

CARDIOMYOPATHIES; CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HUMANS; RISK FACTORS;

EID: 79952835599     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Hinkle LE, Thaler HT. Clinical classification of cardiac deaths. Circulation, 1982; 65: 457-464.
2. Leach IH, Blundell JW, Rowley JM, Turner DR. Acute ischaemic lesions in death due to ischaemic heart disease. An autopsy study of 333 cases of out-of-hospital death. Eur Heart J, 1995; 16: 1181-1185.
3. De Vreede-Swagemakers J, Gorgels AP, Dubois-Arbouw WI et al. Out-of-hospital cardiac arrest in the 1990's: A population-based study in the Maastrict area on incidence, characteristics and survival. J Am Coll Cardiol, 1997; 30: 1500-1505.
4. Thomas AC, Knapman PA, Krikler DM, Davies MJ. Community study of the causes of 'natural' sudden death. BMJ, 1988; 297: 1453-1456.
5. Krahn AD, Healey JS, Chauhan V et al. Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors with Preserved Ejection Fraction Registry (CASPER). Circulation, 2009; 120: 278-285.
6. Albert CM, Mittleman MA, Chae CU et al. Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med, 2000; 343: 1355-1361.
7. Mittleman MA, Maclure M, Tofler GH et al. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med, 1993; 329: 1677-1683.
8. Schwartz PJ, Priori SG, Spazzolini C et al. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation, 2001; 103: 89-95.
9. Keller DI, Rougier JS, Kucera JP et al. Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations. Cardiovasc Res, 2005; 67: 510-519.
10. Schwartz PJ, Spazzolini C, Crotti L et al. The Jervell and Lange--Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation, 2006; 113: 783-790.
11. Bayes de LA, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J, 1989; 117: 151-159.
12. Lee S, Wellen HJJ, Josephson ME. Paroxysmal atrioventricular block. Heart Rhythm, 2009; 6: 1229-1234.
13. Smits JP, Eckardt L, Probst V et al. Genotype-phenotype relationship in Brugada syndrome: Electrocardiographuc features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol, 2002; 40: 350-356.
14. Das MK, Suradi H, Maskoun W et al. Fragmented wide QRS on a 12-lead ECG: A sign of myocardial scar and poor prognosis. Circ Arrhythm Electrophysiol, 2008; 1: 258-268.
15. Maskoun W, Suradi H, Mahenthiran J, Bhakta D, Das M. Fragmented QRS complexes on a 12-lead ECG predict arrhythmic events in patients with ischemic cardiomyopathy who receive an ICD for primary prophylaxis. Heart Rhythm, 2007; 4: S211-S212.
16. Savard P, Rouleau JL, Ferguson J et al. Risk stratification after myocardial infarction using signal averaged electrocardiographic criteria adjusted for sex, age, and myocardial infarction location. Circulation, 1997; 96: 202-213.
17. Marcus FI, McKenna WJ, Sherrill D et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Proposed modification of the Task Force criteria. Circulation, 2010; 121: 1533-1541.
18. Rautaharju PM, Surawicz B, Gettes LS et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: Part IV. The ST segment, T and U waves, and the QT interval. J Am Coll Cardiol, 2009; 53: 982-991.
19. Bazett HC. An analysis of the time-relations of electrocardiograms. Heart, 1920; 7: 35-70.
20. Chauhan VS, Tang AS. Dynamic changes of QT interval and QT dispersion in non-Q-wave and Q-wave myocardial infarction. J Electrocardiol, 2001; 34: 109-117.
21. Drory Y, Ouaknine G, Kosary IZ et al. Electrocardiographic findings in brain death; description and presumed mechanism. Chest, 1975; 67: 425-432.
22. Mattu A, Brady WJ, Perron AD. Electrocardiographic manifestations of hypothermia. Am J Emerg Med, 2002; 20: 314-326.
23. Myerburg RJ, Kessler KM, Mallon SM et al. Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary artery spasm. N Engl J Med, 1992; 326: 1451-1455.
24. Peters RH, Wever EF, Hauer RN, Robles de Medina EO. Low prevalence of coronary artery spasm in patients with normal coronary angiograms and unexplained ventricular fibrillation. Eur Heart J, 1998; 19: 1070-1074.
25. Abdel-Aty H, Simonetti O, Friedrich MG. T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imag, 2007; 26: 452-459.
26. Nazarian S, Bluemke DA, Lardo AC et al. Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy. Circulation, 2005; 112: 2821-2825.
27. Bogun FM, Desjardins B, Good E et al. Delayed-enhanced magnetic resonance imaging in nonischemic cardiomyopathy: Utility for identifying the ventricular arrhythmia substrate. J Am Coll Cardiol, 2009; 53: 1138-1145.
28. Adabag AS, Maron BJ, Appelbaum E et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement in cardiovascular magnetic resonance. J Am Coll Cardiol, 2008; 51: 1369-1374.
29. Tandri H, Castillo E, Ferrari VA et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol, 2006; 48: 2277-2284.
30. Wong JA, Gula LJ, Klein GJ, Yee R, Skanes AC, Krahn AD. Utility of treadmill testing in identification and genotype prediction in long-QT syndrome. Circ Arrhythm Electrophysiol, 2010; 3: 120-125.
31. Chattha IS, Sy RW, Yee R et al. Utility of the recovery electrocardiogram after exercise: A novel indicator for the diagnosis and genotyping of long QT syndrome? Heart Rhythm, 2010; 7: 906-911.
32. Amin AS, de Groot EA, Ruijter JM, Wilde AM, Tan HL. Exercise-induced ECG changes in Brugada syndrome. Circ Arrhythm Electrophysiol, 2009; 2: 531-539.
33. Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation, 1997; 96: 2987-2991.
34. Shimizu W, Noda T, Takaki H et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. J Am Coll Cardiol, 2003; 41: 633-642.
35. Khositseth A, Hejlik J, Shen W-K, Ackerman MJ. Epinephrine induced T-wave notching in congenital long QT syndrome. Heart Rhythm, 2005; 2: 141-146.
36. Vyas H, Hejlik J, Ackerman MJ. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: Diagnostic accuracy of the paradoxical QT response. Circulation, 2006; 113: 1385-1392.
37. Kawataki M, Kashima T, Toda H, Tanaka H. Relation between QT interval and heart rate: Applications and limitations of Bazett's formula. J Electrocardiol, 1984; 17: 371-375.
38. Krahn AD, Gollob M, Yee R et al. Diagnosis of unexplained cardiac arrest: Role of adrenaline and procainamide infusion. Circulation, 2005; 112: 2228-2234.
39. Wilde AAM, Antzelevitch C, Borggrefe M et al. Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J, 2002; 23: 1648-1654.
40. Sangwatanaroj S, Prechawat S, Sunsaneewitayakul B, Sitthisook S, Tosukhowong P, Tungsanga K. New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives. Eur Heart J, 2001; 22: 2290-2296.
41. Watanabe A, Kusano KF, Morita H et al. Low-dose isoproterenol for repetitive ventricular arrhythmia in patients with Brugada syndrome. Eur Heart J, 2006; 27: 1579-1583.
42. Buxton AE, Lee KL, DiCarlo L et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med, 2000; 342: 1937-1945.
43. Poll DS, Marchlinski FE, Buxton AE et al. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol, 1986; 58: 992-997.
44. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med, 1997; 337: 1576-1583.
45. Corrado D, Calkins H, Link MS et al. Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia. Circulation, 2010; 122: 1144-1152.
46. Roux JF, Dubuc M, Pressacco J et al. Concordance between an electroanatomic mapping system and cardiac MRI in arrhythmogenic right ventricular cardiomyopathy. Pacing Clin Electrophysiol, 2006; 29: 109-112.
47. Rougin A, Bomma CS, Nasir K et al. Implantable cardioverter--defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol, 2004; 43: 1843-1853.
48. Bai R, Napolitano C, Bloise R, Monteforte N, Priori S. Yield of genetic screening in inherited cardiac channelopathies. How to prioritize access to genetic testing. Circ Arrhythmia Electrophysiol, 2009; 2: 6-15.
49. Heart Rhythm UK Familial Sudden Death Syndromes Statement Development Group. Clinical indications for genetic testing in familial sudden death syndromes: an HRUK position statement. Heart, 2008; 94: 502-507.